• Devices
    • Medical Remanufacturing
    • Catalogue
    • Electrophysiology
      • CARTO3
      • EnSite Precision
    • Surgical Instruments
      • Harmonic
    • Purchase of used medical devices
    • eIFU
  • About us
    • Sustainability
    • Economy
    • Safety
    • AMDR
  • Career
  • News
  • Downloads
    • eIFU
  • Contact
  • LogIn
  • English
    • Deutsch
    • English
    • Español
    • Nederlands
    • Français
    • Svenska
    • Dansk
    • Português
    • Norsk Bokmål
    • Belgique
    • Hrvatski
    • Slovenščina
AMDR publishes procurement policy to protect reprocessing programmes

AMDR publishes procurement policy to protect reprocessing programmes

by MarketingVanguard | 22. October 2025 | News (en)

AMDR publishes procurement policy to protect reprocessing programmes The Association of Medical Device Reprocessors (AMDR) has introduced a new template for hospitals and healthcare systems:the „Reprocessing and Fair Contracting Policy Template“. This document is...
New Operations Team: Stronger Collaboration and Streamlined Processes

New Operations Team: Stronger Collaboration and Streamlined Processes

by MarketingVanguard | 7. October 2025 | News (en)

We are restructuring our Operations Team to strengthen collaboration between our sites in Aschersleben, Berlin and Friedeburg, and to further enhance the efficiency of our processes. The Operations Team brings together the Executive Board, Technical Services and...
Denmark Promotes Remanufacturing: Hospitals Benefit from Funding

Denmark Promotes Remanufacturing: Hospitals Benefit from Funding

by MarketingVanguard | 24. September 2025 | News (en)

Since 1 January 2025, it has been officially permitted in Denmark to have highly specialised single-use medical devices reprocessed. To make it easier for hospitals to adopt this practice, financial support has been introduced: DKK 0.5 million in 2025, DKK 1.5 million...
How Cardiac Catheters Gain a Second Life: Vanguard AG in Klinergie Magazin 2025

How Cardiac Catheters Gain a Second Life: Vanguard AG in Klinergie Magazin 2025

by Clemens Köhler | 10. September 2025 | News (en)

At the heart of the article is the work of our Research and Development (R&D) department, which ensures that all processes within Medical Remanufacturing comply with regulatory requirements – including the EU Medical Device Regulation (MDR), the Implementing...
MedTech meets agriculture: Agroforestry project

MedTech meets agriculture: Agroforestry project

by Clemens Köhler | 27. August 2025 | News (en)

That’s why Vanguard AG is now sponsoring an agroforestry system. This year, the innovative agricultural company Gut&Bösel, together with the Finck Foundation, established an agrosilvopastoral agroforestry system spanning 26,5 hectares, featuring nearly 8...
New Products in the Portfolio: Soundstar® Ultrasound Catheter and Farastar Catheter Connection Cable

New Products in the Portfolio: Soundstar® Ultrasound Catheter and Farastar Catheter Connection Cable

by Clemens Köhler | 14. August 2025 | News (en)

Soundstar® Ultrasound Catheter Four versions of the Soundstar® ultrasound mapping catheter with 3D mapping functionality are now available as CS-certified reprocessed products: Farastar Catheter Connection Cable The Farastar Catheter Connection Cable from Boston...
« Older Entries
Next Entries »

Recent Posts

  • Circular Economy Hub Berlin: New Learning Platform Brings the Circular Economy to Life
  • Position Paper on Sustainability in Electrophysiology: Why Collaborative Solutions Are Now Needed
  • Welt der Wunder Green Life Visits Vanguard
  • Study Quantifies the Carbon Footprint of Atrial Fibrillation Ablation and Highlights Where the Greatest Opportunity for Reduction Lies
  • Two teams, strong team spirit: Vanguard at the 5×5 team relay in Tiergarten

Recent Comments

No comments to show.

Vanguard AG
Landsberger Str. 222
12623 Berlin
Deutschland
Kundenservice: 030 - 318 73 43 - 300

Vanguard Medical Devices Limited
The Scalpel, 18th Floor, 52 Lime Street
London EC3M 7AF
UK

International customer service:
+49 30 - 318 73 43 - 300

© 2026 Vanguard AG. All rights reserved.

Impressum   Datenschutzerklärung   AGB   Kontakt   Datenschutzhinweise für Aktionäre